Skip to main content
. 2021 Mar 18;18(4):1491–1506. doi: 10.1021/acs.molpharmaceut.0c01238

Table 2. Selected Examples of Nanoparticle-Based RNA Formulations for in Vivo Brain Delivery via Systemic Administrationa.

formulation nucleic acid animal model target ref
Lipid-Based NPs
Angiopep-2- targeted liposomes GOLPH3siRNA U87-GFP-Luciferase-bearing BALB/c mouse LRP-1 (72)
RVG-9r-targeted liposomes Ataxin3 siRNAs C57 BL/6 ataxin-3 [Q69]-transgenic nACh (73)
Calcium phosphate lipid NPs SOD1 Transgenic zebrafish   (74)
ASO
Polymeric NPs
GLUT-1 targeted polymeric NPs MALAT1-ASO BALB/c mice Glucose transporter (75)
PBAE NPs siRNA Orthotopic GBM1A mouse model   (76)
Hybrid NPs
Angiopep-2 lipid-PLGA NPs GOLPH3 Nude U87 xenograft mice LRP-1 (77)
siRNA
Cyclodextrin
Transferrin targeted CD RRM2 Monkeys Transferrin receptor (78)
siRNA
Exosomes
RVG-targeted exosomes BACE1 C57BL/6 nACh (79)
siRNA
T7-peptide targeted exosomes microRNA-21 ASO Glioblastoma rat model Transferrin receptor (80)
a

Abbreviations: CD, cyclodextrin; GOLPH3, Golgi phosphoprotein 3; LRP-1, low density lipoprotein receptor-related protein 1; nACh, nicotinic acetylcholine receptor; NPs, nanoparticles; PBAE, poly(β-aminoester); RRM2, ribonucleotide reductase subunit M2; RVG, rabies virus glycoprotein; SOD, superoxide dismutase I.